Funds holding iShares U.S. Pharmaceuticals E
ISIN US4642888360 · United States · LEI 549300K3OFF3L3ODU217
- Fund holders
- 1
- Of which ETFs
- 0 1 other fund
- Value held
- 618K $
A single tracked fund declares this security. So these figures do not say who holds it.
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| SGI Small Cap Core Fund RBB Fund, Inc. | 6,729 | 618K $ | 0.51 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of this security in each fund.
| Fund | Weight in fund | |
|---|---|---|
| SGI Small Cap Core Fund RBB Fund, Inc. | 0.51 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 1 | -2 | 6,729 | -98.4 % |
| 2026Q1 | 3 | +2 | 415,449 | +307,640.0 % |
| 2025Q4 | 1 | 0 | 135 | 0.0 % |
| 2025Q3 | 1 | 0 | 135 | -99.5 % |
| 2025Q2 | 1 | 0 | 26,868 | +131.7 % |
| 2024Q4 | 1 | -1 | 11,595 | -94.9 % |
| 2024Q3 | 2 | -1 | 226,896 | +39.8 % |
| 2024Q2 | 3 | +2 | 162,289 | +1,232.2 % |
| 2023Q4 | 1 | 12,182 |
Institutional managers
194 managers declare this security to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| Fisher Asset Management, LLC | 2,767,359 | 239.9M $ | as of Mar 31, 2026 |
| Foundations Investment Advisors, LLC | 689,274 | 59.7M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 480,268 | 41.6M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 456,606 | 39.6M $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 375,746 | 31.6M $ | as of Mar 31, 2026 |
| Aptus Capital Advisors, LLC | 286,543 | 24.8M $ | as of Mar 31, 2026 |
| McElhenny Sheffield Capital Management, LLC | 202,612 | 17.6M $ | as of Mar 31, 2026 |
| LPL Financial LLC | 170,188 | 14.8M $ | as of Mar 31, 2026 |
| Anfield Capital Management, LLC | 129,577 | 11.2M $ | as of Mar 31, 2026 |
| Insight Wealth Strategies, LLC | 118,692 | 10.3M $ | as of Mar 31, 2026 |
| ROYAL BANK OF CANADA | 116,293 | 10.1M $ | as of Mar 31, 2026 |
| Cetera Investment Advisers | 109,471 | 9.5M $ | as of Mar 31, 2026 |
| PREVAIL INNOVATIVE WEALTH ADVISORS, LLC | 93,112 | 8.1M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 79,908 | 6.9M $ | as of Mar 31, 2026 |
| Virtue Capital Management, LLC | 76,344 | 6.4M $ | as of Mar 31, 2026 |
| BROWN ADVISORY INC | 75,432 | 6.5M $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 69,932 | 6.1M $ | as of Mar 31, 2026 |
| RAYMOND JAMES FINANCIAL INC | 66,738 | 5.8M $ | as of Mar 31, 2026 |
| Cadent Capital Advisors, LLC | 61,616 | 5.3M $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 60,401 | 5.2M $ | as of Mar 31, 2026 |
| Concurrent Investment Advisors, LLC | 57,188 | 5M $ | as of Mar 31, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | 53,289 | 4.6M $ | as of Mar 31, 2026 |
| Concord Investment Counsel Inc. | 49,158 | 4.3M $ | as of Mar 31, 2026 |
| AMERIPRISE FINANCIAL INC | 46,842 | 4.1M $ | as of Mar 31, 2026 |
| AdvisorNet Financial, Inc | 40,993 | 3.6M $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding iShares U.S. Pharmaceuticals E". https://titelia.com/en/stocks/ishares-u-s-pharmaceuticals-e-US4642888360